CEACAM5 | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Conferences Trial results

10 September 2024

World Lung 2024 – a way forward for CEACAM5?

Patients' expression of CEACAM5 might hold the key to activity after all.

Trial results

21 December 2023

Sanofi switches to another CEACAM5 asset

Subscribe to CEACAM5